See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2024_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.8389117629815479, 'aggregate_val': 2603386000, 'exp_sum': 1415721000, 'exp_to_value': {'LiabilitiesCurrent': 448090000, 'LiabilitiesNoncurrent': 412059000, 'remainder_Liabilities': 555572000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,641,853,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 71,043,000 |
| 3 | remainder_Assets | 277,176,000 |
| 4 | LiabilitiesCurrent | 448,090,000 |
| 5 | LiabilitiesNoncurrent | 412,059,000 |
| 6 | remainder_Liabilities | 1,743,237,000 |
| 7 | CostOfGoodsAndServicesSold | 9,386,242 |
| 8 | SellingGeneralAndAdministrativeExpense | 248,416,864 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 997,588,959 |
| 11 | remainder_Revenues | 730,204,621 |
| 12 | remainder_NetIncome | 125,075,207 |
| 13 | remainder_ComprehensiveNetIncome | 6,890,185 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,990,072,000 |
| 1 | Liabilities | 2,603,386,000 |
| 2 | Expenses | 1,255,392,065 |
| 3 | Revenues | 730,204,621 |
| 4 | StockholdersEquity | 386,686,000 |
| 5 | NetIncome | -400,112,237 |
| 6 | ComprehensiveNetIncome | -396,667,144 |
| 7 | BaseVar | 3,855,510,039 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.160 |
| 9 | EconomicCapitalRatio | 1.57 |
Edgar->Model Mapping
Feature Distribution
Change over Time
